Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:07 AM
Ignite Modification Date:
2025-12-26 @ 11:07 AM
NCT ID:
NCT07267312
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years at the time of presentation.
* Both sexes.
* Confirmed diagnosis of coronary artery disease (CAD), established by clinical presentation, electrocardiographic findings, elevated cardiac biomarkers, and/or angiographic evidence of ≥50% luminal stenosis in at least one major coronary artery.
* Hospital admission to the participating cardiology department between \[insert study period, e.g., January 2020 and December 2024\] for acute coronary syndrome (ACS), including unstable angina, non-ST-elevation myocardial infarction (NSTEMI), or ST-elevation myocardial infarction (STEMI).
* Availability of complete clinical, laboratory, and echocardiographic data necessary for classification and analysis.
Exclusion Criteria:
* Incomplete medical records or missing essential laboratory, imaging, or demographic data.
* Secondary causes of dyslipidemia, including uncontrolled hypothyroidism, nephrotic syndrome, chronic liver disease, or use of lipid-altering medications (other than statins) before presentation.
* Previous congenital or structural heart disease, cardiomyopathy, or significant valvular heart disease unrelated to CAD.
* Severe chronic kidney disease (estimated glomerular filtration rate \<30 mL/min/1.73 m²) or patients on dialysis.
* Autoimmune, inflammatory, or systemic diseases known to influence vascular inflammation or lipid metabolism.
* Malignancy or life expectancy \<6 months due to non-cardiac causes.
* Pregnant or lactating women.
* Non-Saudi patients (focusing on Saudi population in southern region).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07267312
Study Brief:
Protocol Section:
NCT07267312